John M. Wesolowski - 06 Mar 2024 Form 4 Insider Report for INTENSITY THERAPEUTICS, INC. (INTS)

Role
Principal Accounting Officer and Controller
Signature
/s/ Daniel L. Woodard, Attorney-in-Fact
Issuer symbol
INTS
Transactions as of
06 Mar 2024
Transactions value $
$0
Form type
4
Filing time
07 Mar 2024, 18:06:55 UTC
Previous filing
21 Jul 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INTS Stock Option (right to buy Common Stock) Award $0 +25K $0.00 25K 06 Mar 2024 Common Stock 25K $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest, subject to the individual's continued employment with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on March 6, 2025.

Remarks:

Principal Accounting Officer and Controller